• The Korea Times
  • search
search close
Reporter : Kim Bo-eun
Thu, June 8, 2023 | 10:12
Kyobo-Affinity feud deepening ahead of IPO
Kyobo Life Insurance is seeking to settle its years-long conflict with financial investors, as its initial public offering (IPO) is only months away, but the feud is instead escalating, posing uncertainties for the company's stock market debut.
Companies | 2022-01-18 17:25
Yoon-related stocks spike after clearing 'Kim phone call risk'
Stocks related to main opposition People Power Party's presidential candidate Yoon Suk-yeol surged Monday, after a local broadcaster's airing of personal phone calls between Yoon's wife Kim Keon-hee and a YouTube channel reporter turned out not to be as damaging as expected to Yoon, maintaining his chances of being elected.
Markets | 2022-01-17 16:58
Cryptocurrency exchange operators face audit amid money laundering concerns
The country's major cryptocurrency exchange operators will come under inspection by the financial regulator for the first time, amid growing concern that the exchanges might have been used for money laundering.
Markets | 2022-01-17 15:02
India emerging as promising EV market
Carmakers are increasingly focusing on India's market for electric vehicles (EV), given that it is projected to grow substantially in the coming years, as the country accelerates its drive to tackle air pollution and reduce its dependency on oil.
Companies | 2022-01-16 16:51
Foreign businesses call for 'clarity' in Korea's industrial accident law
Foreign businesses operating here are calling on the Korean government to ensure more “clarity” and “predictability” in a strengthened law over serious industrial accidents, claiming that it could hamper foreign investment and force many of them to consider pulling out of Korean markets. Foreign firms share the view that industrial accidents need to be prevented, but there ar...
Companies | 2022-01-16 15:25
Novavax COVID-19 vaccine gets approval
A worker is seen at SK Bioscience's plant manufacturing the COVID-19 vaccine of U.S. biotech company Novavax in Andong, North Gyeongsang Province, in this photo. The Ministry of Food and Drug Safety on Wednesday authorized the use of Novavax's COVID-19 vaccine.
Bio | 2022-01-12 17:28
Korea's Sputnik V production consortium faces uncertainties
Almost a year has passed since the Hankook Korus Pharm-led consortium was assigned to produce Russia's COVID-19 vaccine, Sputnik V, but production continues to be delayed.
Companies | 2022-01-12 15:57
Apple to allow app developers to use outside payments
Apple said it will comply with a ruling to allow payment systems other than its own in its App Store, Korea's ICT regulator said Tuesday. Apple had been mum about its plans after the introduction of related regulations last year, but it finally released its stance, following Google's decision to comply with the revised law last month.
Companies | 2022-01-11 16:31
Kakao CEO nominee Ryu resigns over stock controversy
Kakao stated Monday that its co-CEO nominee, Ryu Young-joon, would not take the top post at the tech giant, following a snowballing controversy over his selloff of Kakao affiliate stocks.
Companies | 2022-01-10 16:54
Severance Hospital tops industry-wide NCSI ranking for 2021
Severance Hospital topped the industry-wide customer satisfaction NCSI ranking this year, with 84 points. The NCSI ranking is determined based on customer evaluations of the companies' products and services. The index is released on an annual basis to enhance the competitiveness of firms and industries.
Companies | 2022-01-09 13:14
123456 7 8910
Roland Garros 2023
Copyright